Fc-Receptor Targeted Therapies for the Treatment of Myasthenia gravis

Myasthenia gravis (MG) is an autoimmune disease in which immunoglobulin G (IgG) antibodies (Abs) bind to acetylcholine receptors (AChR) or to functionally related molecules in the postsynaptic membrane at the neuromuscular junction. IgG crystallizable fragment (Fc)-mediated effector functions, such...

Descripción completa

Detalles Bibliográficos
Autores principales: Keller, Christian W., Pawlitzki, Marc, Wiendl, Heinz, Lünemann, Jan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198115/
https://www.ncbi.nlm.nih.gov/pubmed/34071155
http://dx.doi.org/10.3390/ijms22115755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198115/
https://www.ncbi.nlm.nih.gov/pubmed/34071155
http://dx.doi.org/10.3390/ijms22115755

Ejemplares similares